The rise of generative artificial intelligence, such as advanced models like GPT-5, has brought new possibilities for strategic formulation. They can quickly generate strategic plans and simulate ...

Dave Miller, PhD, explains how early formulation planning, novel platforms, and tailored approaches secure long-term protection against generics. *full transcript below In this final part of our ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

Evonik, a global specialty chemicals company, and Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, have entered into a strategic collaboration ...

The emergence of generative artificial intelligence seems to bring new hope, as it can draft plans, generate strategies, and even simulate future scenarios. However, the reality is that technological ...

Cytiva demonstrates that manufacturers must expand their focus to include strategic liquid planning for scale-up.

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company” or ...

The government announced on the 7th a plan to reorganize government organizations after high-level party-government discussions. The plan divides the Ministry of Economy and Finance, transferring its ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

Citations: Ocasio, William, John Joseph. 2005. An Attention Based Theory of Strategy Formulation: Linking Decision Making and Guided Evolution in Strategy Processes. Advances in Strategic Management.

When K-beauty first exploded into the U.S. market years ago, it infamously ignored dark-skinned consumers. Now, as the ...

Scancell Holdings PLC (SCNLF) reports significant progress in cancer vaccine development and financial stability, despite facing operational and regulatory hurdles.